> What is the evidence to show the vaccine is safe for BAME communities?
The Public Assessment Reports contain all the scientific information about the trials and information on trial participants.
For the Pfizer trial, participants included 9.6% black/African, 26.1% Hispanic/Latino and 3.4% Asian.
For the Oxford/AstraZeneca vaccine 10.1% of trial recipients were Black and 3.5% Asian.
There is no evidence either of the vaccines will work differently in different ethnic groups.
> Why are BAME groups not being prioritised?
There is clear evidence that certain Black, Asian and minority ethnic (BAME) groups have higher rates of infection, and higher rates of serious disease and mortality. The reasons are multiple and complex.
There is no strong evidence that ethnicity by itself (or genetics) is the sole explanation for observed differences in rates of severe illness and deaths. What is clear is that certain health conditions are associated with increased risk of serious disease, and these health conditions are often overrepresented in certain Black, Asian and minority ethnic groups.
Prioritisation of people with underlying health conditions will also provide for greater vaccination of BAME communities who are disproportionately affected by such health conditions. Tailored local implementation to promote good vaccine coverage in Black, Asian and minority ethnic groups will be the most important factor within a vaccine programme in reducing health inequalities in these groups.
Healthcare providers have been undertaking staff risk assessments throughout the pandemic to identify individuals at higher risk of contracting the virus and/or experiencing serious illness if they do. These risk assessments include factors such as ethnic background, and are being used as the basis for prioritising access to vaccines for staff over the coming weeks.
> Dispelling some of the myths
> Covid-19 vaccine and the Black Community: A Tyler Perry special
Our chief nurse Michelle Bateman highly recommends watching this!
'American actor, director, producer and screenwriter, Tyler Perry sits down with top medical experts Carlos del Rio, MD Executive Associate Dean, Emory School of Medicine at Grady Health System, and Kimberly Dyan Manning, MD Professor of Medicine at Grady Health System to address the public's concerns and fears about the Covid-19 vaccine. This half-hour special provides helpful and factual information for viewers looking to protect themselves and their families from this virus. Tackling issues head-on, Perry asks the hard-hitting questions to help the BAME community gain insight into this new vaccine.'
> JUCD (Joined Up Care Derbyshire) community representatives' communication toolkit
JUCD has developed some useful toolkits and resources to support staff engaging with members of our community regarding the Covid-19 pandemic, in particular the following communities: African, Caribbean, Bangladeshi & Pakistani community. The information will equally be of interest to our staff from these communities.